Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III TrialLaura Biganzoli, M. Piccart, Luc Duchateau et al.|Journal of Clinical Oncology|2002Cited by 220
AT (doxorubicin-Taxol) versus AC (doxorubicin-cyclophosphamide) as first line chemotherapy in metastatic breast cancer (MBC): A phase III study. (originally presented at ASCO 2000. Abstract 282)M. Piccart, Ron Epelbaum, T. Čufer et al.|Ghent University Academic Bibliography (Ghent University)|2000Cited by 15